Authors:
Wikell, C
Kugelberg, FC
Hjorth, S
Apelqvist, G
Bengtsson, F
Citation: C. Wikell et al., Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathy, CLIN NEUROP, 24(6), 2001, pp. 324-333
Authors:
Wikell, C
Hjorth, S
Apelqvist, G
Kullingsjo, J
Lundmark, J
Bergqvist, PBF
Bengtsson, F
Citation: C. Wikell et al., Sustained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings, N-S ARCH PH, 363(4), 2001, pp. 448-455
Authors:
Apelqvist, G
Wikell, C
Carlsson, B
Hjorth, S
Bergqvist, PBF
Ahlner, J
Bengtsson, F
Citation: G. Apelqvist et al., Dynamic and kinetic effects of chronic citalopram treatment in experimental hepatic encephalopathy, CLIN NEUROP, 23(6), 2000, pp. 304-317
Authors:
Hjorth, S
Bengtsson, HJ
Kullberg, A
Carlzon, D
Peilot, H
Auerbach, SB
Citation: S. Hjorth et al., Serotonin autoreceptor function and antidepressant drug action (vol 14, pg177, 2000), J PSYCHOPH, 14(3), 2000, pp. NIL_1-NIL_1
Citation: S. Hjorth et Ph. Hutson, Introduction - Neuroregulation of serotoninergic systems: basic and clinical perspectives, J PSYCHOPH, 14(2), 2000, pp. 99-99
Authors:
Bengtsson, HJ
Kele, J
Johansson, J
Hjorth, S
Citation: Hj. Bengtsson et al., Interaction of the antidepressant mirtazapine with alpha(2)-adrenoceptors modulating the release of 5-HT in different rat brain regions in vivo, N-S ARCH PH, 362(4-5), 2000, pp. 406-412
Citation: S. Hjorth et al., An analysis of the use of electrical power measurements for process control in large-scale stirred vessels, CAN J CH EN, 78(6), 2000, pp. 1127-1132
Authors:
Wikell, C
Apelqvist, G
Carlsson, B
Hjorth, S
Bergqvist, PBF
Kugelberg, FC
Ahlner, J
Bengtsson, F
Citation: C. Wikell et al., Pharmacokinetic and pharmacodynamic responses to chronic administration ofthe selective serotonin reuptake inhibitor citalopram in rats, CLIN NEUROP, 22(6), 1999, pp. 327-336
Citation: S. Hjorth et Sb. Auerbach, Autoreceptors remain functional after prolonged treatment with a serotoninreuptake inhibitor, BRAIN RES, 835(2), 1999, pp. 224-228